logo
  

Taylor Wimpey Remains On Track To Deliver 2021 Results In Line With Previous View

Taylor Wimpey plc (TW.L) issued trading statement for the second half to date, and said it remains on track to deliver full year 2021 results in line with previous guidance.

The company stated that it has been building a strong forward order book for 2022 and continues to see good demand for its homes, supported by a positive market backdrop. Further, Taylor Wimpey continues to see house price inflation fully offsetting build cost inflation.

Pete Redfern, Chief Executive, commented, "Looking ahead, market conditions remain supportive, and with the benefit of our strong land position we are well placed to deliver against our medium term targets."

The UK housing market has remained positive in the second half of 2021 with good customer demand and mortgage availability. The company expects to deliver full year results in line with its expectations, as outlined at the half year results.

During the second half of the year to the end of October, the company added 5,431 plots to the short term landbank compared to 3,663 plots reported last year.

Looking ahead, the company remains on track to deliver full year 2021 results in line with its previous guidance. Also, the company noted that it would continue to prioritise operating margin, and remain on track to deliver an operating margin target of about 21%-22% in the medium term.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Covid vaccine makers Pfizer Inc. and BioNTech SE announced a new $3.2 billion vaccine supply deal with the U.S. Government, as the country is bracing for a Covid outbreak this fall. Under the deal, the U.S. government will receive 105 million doses (30 µg, 10 µg and 3 µg) of Pfizer -BioNTech covid vaccines initially. The order may include adult Omicron-adapted COVID-19 vaccines. Samsung Electronics Co. has started the initial mass production of 3-nanometer or nm chips, which is considered as the most advanced chip in the world. In its move, the South Korean tech major beats rival Taiwan Semiconductor Manufacturing Co., the world's largest chip manufacturer, which is reportedly in the process to build one. Bryant Ranch Prepack Inc. is recalling certain Morphine Sulfate Extended-Release Tablets citing incorrect labeling, the U.S. Food and Drug Administration said. The recall involves one lot of Morphine Sulfate 30 mg Extended-Release tablets, and one lot of Morphine Sulfate 60 mg Extended-Release tablets to the consumer level.
RELATED NEWS
Follow RTT